| Home > Publications Database > Pooled Analysis of Real-World Evidence Supports Anti-CGRP mAbs and OnabotulinumtoxinA Combined Trial in Chronic Migraine. > Access to Fulltext |
DZNE-2022-01439
|
|||||||
| version 1 |
| ||||||